Adhatoda vasica and Tinospora cordifolia extracts ameliorate clinical and molecular markers in mild COVID-19 patients: a randomized open-label three-armed study

Adhatoda vasica and Tinospora cordifolia extracts ameliorate clinical and molecular markers in mild COVID-19 patients: a randomized open-label three-armed study

Abstract Background SARS-CoV-2 infections caused mild-to-moderate illness. However, a sizable portion of infected people experience a rapid progression of hyper-inflammatory and hypoxic respiratory illness that necessitates an effective and safer remedy to combat COVID-19. Methods A total of 150 COV...

Full description

Bibliographic Details
Main Authors: Mukta Verma, Neha Rawat, Ritu Rani, Manju Singh, Aditi Choudhary, Sarfaraz Abbasi, Manish Kumar, Sachin Kumar, Ankur Tanwar, Bishnu Raman Misir, Sangeeta Khanna, Anurag Agrawal, Mohammed Faruq, Shalini Rai, Richa Tripathi, Anil Kumar, Mukta Pujani, Meera Bhojani, Anil Kumar Pandey, Tanuja Nesari, Bhavana Prasher
Format: Article
Language:English
Published: BMC 2023-12-01
Series:European Journal of Medical Research
Subjects:
COVID-19
Clinical trial
Adhatoda vasica
Tinospora cordifolia
Anti-hypoxic
Anti-inflammatory
Online Access:https://doi.org/10.1186/s40001-023-01507-7

Internet

https://doi.org/10.1186/s40001-023-01507-7

Similar Items